NCT06441812

A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients

A Multicenter, Single-group Phase II Clinical Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of Multiple Subcutaneous Injections of SHR-1703 in Eosinophilic Asthma Patients

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluation the long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients

Conditions

• Eosinophilic Asthma Patients

Interventions

Type	Name	Description
DRUG	SHR-1703 Injection	SHR-1703 Injection

Timeline

• Start date: 2024-07-19
• Primary completion: 2028-09-01
• Completion: 2028-09-01
• First posted: 2024-06-04
• Last updated: 2025-12-18

Locations

1 site across 1 country: China